To date Mesa received $4.5 million in One Arizona settlement funds. The city will give $1 million to nonprofits working to ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...

Distribution of prescribed opioid analgesics is lower in majority non-White versus majority White communities across all levels of socioeconomic deprivation.

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

Journavx is a newly-aproved painkiller that experts say could help Long Island's opioid epidemic. NewsdayTV's Virginia Huie reports.

HONOLULU (HawaiiNewsNow) - There’s a new way to monitor how Hawaii is spending $100 million from nationwide opioid lawsuit ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.